Meta-research: Using Research To Increase The Value Of Health And Medical Research
Funder
National Health and Medical Research Council
Funding Amount
$631,370.00
Summary
Improving the return on investment in health and medical research will produce more and faster discoveries that enhance the lives of all Australians. Many problems in the research process are well known and have been pervasive for decades. I will use the research process to improve the research process. I will improve Australia's health and medical research workforce and the quality of the research they produce, creating benefits in multiple fields that last long into the future.
Enabling Technologies For Design And Delivery Of Novel Vaccines Against Infectious Diseases And Cancer.
Funder
National Health and Medical Research Council
Funding Amount
$925,346.00
Summary
This grant will support research necessary to develop the next generation of vaccines. These will combat diseases caused by bacteria and viruses and can also be used to fight cancer. The broad range of application is made possible through the incorporation of simple molecular features that activate the immune system. The intellectual property that has been developed is protected by a patent portfolio some patents of which are already licenced to the pharmaceutical industry.
System-based Approaches To Inform The Design Of Immunotherapies And Immunodiagnostics Against Chronic Pathogens
Funder
National Health and Medical Research Council
Funding Amount
$849,540.00
Summary
Chronic infectious diseases such as malaria are responsible for an enormous public health burden worldwide. New approaches to develop effective interventions against such pathogens are urgently required. Over the next 5 years, I will use innovative genome-based and systems-levels approaches to discover novel pathogen antigens and host immune pathways that underlie protective immunity, immunomodulatory pathways that can be then targeted for intervention, and biomarkers of immunity or disease.
Structural Biology And Therapeutic Targeting Of Proteins Involved In Infection And Immunity
Funder
National Health and Medical Research Council
Funding Amount
$753,300.00
Summary
Structural biology plays an essential role in uncovering how proteins function at the molecular level, and further facilitates strategies to develop therapeutics targeting the diseases these proteins are involved in. In the proposed work, I will focus on bacterial virulence factors, to develop new antibiotics and vaccination strategies, and proteins involved in innate immunity pathways, to develop therapeutics against a number of associated disorders including chronic inflammatory diseases.
Using Health Literacy (HL) Approaches To Develop And Apply Interventions To Improve Health Services And Generate Equitable Health Outcomes
Funder
National Health and Medical Research Council
Funding Amount
$697,209.00
Summary
Health literacy is the ability to find, understand and use health information and healthcare services effectively. The Fellowship will advance the understanding of health literacy. It will determine how poor health literacy might cause health inequalities and with this information, develop and test interventions to improve the response of the healthcare system. The research will make it easier for disadvantaged and vulnerable people to get care, be understood and have their needs recognised and ....Health literacy is the ability to find, understand and use health information and healthcare services effectively. The Fellowship will advance the understanding of health literacy. It will determine how poor health literacy might cause health inequalities and with this information, develop and test interventions to improve the response of the healthcare system. The research will make it easier for disadvantaged and vulnerable people to get care, be understood and have their needs recognised and met.Read moreRead less
Targeting Glycointeractions To Generate New Opportunities To Treat And Prevent Bacterial Infections.
Funder
National Health and Medical Research Council
Funding Amount
$774,540.00
Summary
Bacteria and bacterial toxins can interact with complex sugar structures on human cells called glycans. My research team has identified new and important glycan interactions used by bacteria that cause diseases ranging from pneumonia, meningitis and food borne infections to urinary tract and sexually transmitted diseases. Now that these interactions have been discovered, they can be exploited to create drugs and vaccines that may treat and prevent disease by blocking the glycan interactions.
Research Fellowship: Understanding G Protein-coupled Receptors (GPCRs)
Funder
National Health and Medical Research Council
Funding Amount
$444,177.00
Summary
This project focuses on drug action at G protein-coupled receptors (GPCRs), the largest class of drug targets. It builds on key discoveries by the applicant that novel sites on GPCRs can be targeted by small molecules in a selective manner, thus minimizing side effects and maximizing therapeutic efficacy. Because this approach can work across most GPCR families, the relevance to the pharmaceutical industry and GPCR-related diseases, such as schizophrenia and diabetes, is very high.
Peptides (mini proteins) have outstanding potential as new drugs for cancer, pain and many other diseases, but their potential has not been realised so far because peptides tend to be unstable in the body. I have discovered a new class of peptides that are ultra-stable and have very favourable pharmaceutical properties. I will use these peptides to develop a new generation of drugs that are more potent and with fewer side effects than traditional drugs.
Modulating Protein-Protein Interactions In Disease
Funder
National Health and Medical Research Council
Funding Amount
$863,910.00
Summary
Most diseases are driven by protein-protein interactions often with few/no greasy pockets to fit small molecule drugs. Innovative approaches to new drugs are needed for these proteins. This project combines chemistry, biochemistry and pharmacology to create new drug leads, new knowledge on drug action and disease development at gene, protein, cell, animal levels, and aims to trial new drug leads in preclinical and eventually clinical tests in inflammatory and metabolic diseases, pain and cancer.
Small Molecule Therapeutics: From Infectious And Parasitic Diseases To Cancers
Funder
National Health and Medical Research Council
Funding Amount
$763,845.00
Summary
I will lead a team of medicinal chemists to discover better treatments of diseases focused in two major domains. On one hand, I will discover new drugs to treat certain parasitic diseases such as Sleeping Sickness, Chagas disease and malaria, all caused by protozoal parasites. On the other hand, I will discover new drugs to treat certain cancers, in particular acute myeloid leukemia and Burkitt’s lymphoma, caused by dysfunction of certain types of enzymes called histone acetyltransferases.